Initial 3-month dynamics of dehydroepiandrosterone sulfate can predict responsiveness to primary androgen deprivation therapy in patients with metastatic prostate cancer.
- Author:
Akihiro YANO
1
;
Makoto KAGAWA
1
;
Hideki TAKESHITA
1
;
Yohei OKADA
1
;
Makoto MOROZUMI
1
;
Satoru KAWAKAMI
1
Author Information
- Publication Type:Letter
- MeSH: Aged; Aged, 80 and over; Androgen Antagonists/therapeutic use*; Biomarkers, Tumor/blood*; Dehydroepiandrosterone Sulfate/blood*; Humans; Male; Middle Aged; Prostatic Neoplasms/mortality*; Prostatic Neoplasms, Castration-Resistant/mortality*; Survival Analysis; Treatment Outcome
- From: Asian Journal of Andrology 2019;21(6):635-636
- CountryChina
- Language:English
